Solid Subtype Predicts Early Bone Metastases in Sensitive EGFR-Mutated Lung Adenocarcinoma Patients After Surgery

被引：0
|
作者：
Xiong, A. [1 ]
Li, C. [1 ]
Xu, J. [1 ]
Yang, X. [1 ]
Nie, W. [1 ]
Zhong, H. [1 ]
Chu, T. [1 ]
Zhang, W. [1 ]
Zhong, R. [1 ]
Pan, F. [1 ]
Shen, Y. [1 ]
Lou, Y. [1 ]
Zhang, B. [1 ]
Han, B. [1 ]
Zhang, X. [1 ]
机构：
[1] Shanghai Chest Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
Histologic subtype; non-small cell lung cancer; Distant metastasis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP12.06
引用
收藏
页码：S966 / S967
页数：2
相关论文
共 50 条
  • [1] Solid subtype predicts early bone metastases in sensitive EGFR-mutated lung adenocarcinoma patients after surgery
    Xiong, Anning
    Li, Changhui
    Xu, Jianlin
    Yang, Xiaohua
    Nie, Wei
    Zhong, Hua
    Chu, Tianqing
    Zhang, Wei
    Zhong, Runbo
    Pan, Feng
    Shen, Yinchen
    Lou, Yuqing
    Zhang, Bo
    Han, Baohui
    Zhang, Xueyan
    LUNG CANCER, 2021, 154 : 124 - 130
  • [2] PATIENTS WITH EGFR-MUTATED LUNG ADENOCARCINOMA AFTER PROGRESSION
    Li, Ling
    Tian, Jiyuan
    Sun, Haiyan
    ACTA MEDICA MEDITERRANEA, 2023, 39 (03): : 707 - 713
  • [3] Afatinib After Progression on Osimertinib in Patients with EGFR-Mutated Lung Adenocarcinoma
    Aredo, J.
    Wakelee, H. A.
    Neal, J.
    Padda, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S619 - S619
  • [4] Presence of High-Grade Subtype Predicts Recurrence of Stage I Lung Adenocarcinoma Only in EGFR-Mutated Patients
    Ichinose, J.
    Kondo, Y.
    Ninomiya, H.
    Yamamichi, T.
    Omura, K.
    Hashimoto, K.
    Matsuura, Y.
    Nakao, M.
    Ishikawa, Y.
    Okumura, S.
    Satoh, Y.
    Mun, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S908 - S908
  • [5] First-Line Gefitinib for EGFR-Mutated Lung Adenocarcinoma Patients with Bone Metastases - A Single Institution Experience
    Radosavljevic, Davorin
    Spasic, Jelena
    Stanic, Nemanja
    Ristic, Marija
    Ratknic, Milos
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1233 - S1233
  • [6] Bone metastasis reduces responsiveness to EGFR-TKIs in patients with EGFR-mutated advanced lung adenocarcinoma
    Zheng, X.
    Huang, C.
    Lin, G.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] A nomogram for predicting brain metastases of EGFR-mutated lung adenocarcinoma patients and estimating the efficacy of therapeutic strategies
    Wang, Jing
    Zhang, Baozhong
    Pang, Qingsong
    Zhang, Tian
    Chen, Xi
    Er, Puchun
    Wang, Yuwen
    You, Jinqiang
    Wang, Ping
    JOURNAL OF THORACIC DISEASE, 2021, 13 (02) : 883 - 892
  • [8] Bone metastasis reduces responsiveness to EGFR-TKIs in patients with EGFR-mutated advanced lung adenocarcinoma.
    Jiang, Kan
    Lin, Gen
    Zheng, Xinlong
    Long, Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] An Effective Treatment for EGFR-mutated Lung Adenocarcinoma with Symptomatic Leptomeningeal Metastases Using Aumolertinib
    Zhang, X.
    Wu, Y.
    Hu, Y.
    Zhang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S415 - S415
  • [10] GefitinibAcquired drug resistance in EGFR-mutated bone metastasised lung adenocarcinoma: case report
    Reactions Weekly, 2019, 1778 (1) : 214 - 214
12345